- Continue Shopping
- Your Cart is Empty
Advancing space medicine knowledge aboard the ISS. Another space mission for Astroskin / Bio-Monitor!
Earlier this month, European Space Agency astronaut Luca Parmitano conducted validation tests on-orbit and wore the Astroskin garment and headband connected to the data unit for his first 72-hour monitoring experience.
Luca Parmitano also conducted maintenance operations for the Astroskin / Bio-Monitor that was deployed on the ISS orbiting lab, last December by Canadian Astronaut David Saint-Jacques.
Although the ISS is equipped with health and life sciences research tools, the existing instrumentation for continuous and simultaneous recording of several physiological parameters was lacking. To address this issue, the Canadian Space Agency's Bio-Monitor Commissioning activity uses the Astroskin / Bio-Monitor system; a complete vital signs monitoring platform coupled with a wearable garment capable of monitoring relevant physiological parameters in a non-invasive and non-interfering way during a normal day in space.
The physiological parameters which can be monitored consist of blood pressure, peripheral blood oxygen saturation, 3-lead ECG, respiration, skin temperature, and activity, will help push further our understanding of Vascular aging and Human Physiology in space.
Venturing into the environment of space, microgravity can have negative effects on the human body. When astronauts return to Earth, their carotid arteries, which carry blood to the head and neck, appear to have aged 20 to 30 years. Artery walls become stiffer and thicker in space, the same as when people grow older on Earth.
“You can take extremely healthy, fit astronauts and put them in an environment that restricts their ability to do daily exercise, and they run the risk of developing insulin resistance that on Earth could lead to Type II diabetes,” said principal investigator Richard L. Hughson of Schlegel-University of Waterloo in Ontario
Now operational the Astroskin Bio-Monitor system is available for the next five years to conduct Health research in Space for all participating countries to the International Space Station.
Sometimes you wear the experiment: the Bio-Monitor smart shirt system measures vital signs like temperature, heart rate, respiration and movement, and transmits the data to a tablet application. #MissionBeyond @csa_asc pic.twitter.com/2h6lmRUyHH
— Luca Parmitano (@astro_luca) 19 août 2019
Source:
NASA. 2019. ISS Daily Summary Report - 8/14/2019
NASA. 2019. ISS Daily Summary Report - 8/13/2019
About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.
Hexoskin to build world’s largest database of vital signs for Myalgic Encephalomyelitis patients with ICANCME Research Network
Montreal, Canada, August 22, 2019 - The CIHR (Canadian Institutes of Health Research) organized a press conference at CHU Sainte-Justine, Mother and Child University Hospital Center today to announce the funding of a five-year project to collect biological and vital signs data from patients suffering from Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), to improve medical knowledge of the disease. Canadian Minister of Health, the Honourable Ginette Petitpas Taylor, was at the event to make the announcement with Dr. Alain Moreau, Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases.
In Canada, over half a million Canadians suffer from ME. According to the CDC (Center for Disease Control and Prevention), in the United States, 836,000 to 2.5 million Americans suffer from ME, but most of them have not been diagnosed. There is currently no biological diagnostic test for ME. The disease is diagnosed based on symptoms and by ruling out other conditions that could be causing the symptoms. The CHIR funded project will build the largest long-term cardiopulmonary and activity database in the world for patients with ME.
Hexoskin, a Montreal-based leader in smart clothing, health software, and AI services will provide its health monitoring solutions to support building the database. Pierre-Alexandre Fournier, CEO of Hexoskin, is pleased by today’s announcement: ‘’We believe this project will help us understand how to better take care of patients presenting symptoms of ME. Recent data shows that the prevalence of this disease is higher than previously estimated and has an enormous impact on Canadians living with ME and our society. Data collected in this project will impact millions of lives’’.
Dr. Alain Moreau will be the Principal Investigator with the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis - ICANCME - Research Network: “Myalgic Encephalomyelitis (ME) is possibly the last medical enigma of the 21st century. Our scientific partnership with Hexoskin will be instrumental to address the complexity of ME given its clinical heterogeneity and phenotypic variability overtime. The Hexoskin wearable technologies will allow researchers and clinicians to investigate people severely affected by ME (housebound or bedridden), which is rarely done due to their limited capacity to participate in clinical studies.”
Learn more on Health Research with Hexoskin.
To order, visit the Hexoskin Online Store or contact sales@hexoskin.com.
About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. Hexoskin is an end-to-end system to monitor the user’s general health, vital signs, sleep, and activity, using built-in sensors embedded in Smart Garments made in Canada. The system can be used for a wide range of research domains including cardiology, respiratory, behavioural and physiological psychology, biofeedback, sleep patterns, circadian rhythms, effects of aging on physical performance, human energy expenditure, and physical conditioning.
The Hexoskin smart clothing and solutions were validated in over 70 scientific publications in the fields of cardiology, respiratory, behavioural and physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients in defence, aerospace, security, police and first responders, pharmaceuticals, academics, and healthcare.
Hexoskin is also known for collaborating with the Canadian Space Agency to provide its advanced health technologies Astroskin (Bio-Monitor) to monitor the vital signs of the Canadian Astronaut David Saint-Jacques and future astronauts visiting in the International Space Station for the next five years. The company launched in 2018 the Astroskin platform for research and public/private projects on Earth.
FC Barcelona - Barça Innovation Hub (BIHub) and Allianz align themselves to promote a study on sleep and young athletes
Hexoskin is very proud to be part of this study on sleep and young athletes with FC Barcelona, a world leader in the development of young athletes, and Allianz, one of the world's largest insurers.
Hexoskin has been involved in sleep research since 2012. We share the views of FC Barcelona that we need to do more research on sleep and young athletes to optimize their health and their gameplay. There's more than one way to monitor sleep with Hexoskin smart shirts, and this study allows us to advance of our knowledge of sleep in teenage athletes.
"The information gathered will be processed by doctors at the Adsalutem Institute, and FC Barcelona will provide data on the performance of the analysed athletes to be cross-referenced with those obtained on the quality of their sleep. A study will be shared detailing the conclusions obtained. The Adsalutem Institute has the academic support of the Universitat Internacional de Catalunya (UIC) within the framework of the 'Center for Studies of Sleep Medicine', in which both entities collaborate in the scientific and teaching fields."
About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.
Using Wearables, Data, and AI in Clinical Trials
Montréal InVivo hosted an event today in Laval, Québec, to discuss the use of data and AI in clinical trials. Representatives from Alta Sciences, a CRO focused on phase I/II trials in Canada and the US, and Accreon (Health IT), joined Hexoskin to discuss strategies and best practices.
On the picture below you can see Marc Paquin, Director of Partnerships and Business Development, sharing Hexoskin's experience with wearable sensors & AI software development for clinical trials.
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.
Columbia University Research Measures Impact of Air Pollution on Cyclists in NYC
Commuting by bike is a great way to include physical activity in our day-to-day living. However the impact of air pollution on cyclists is not something that is well understood.
Columbia University researchers Steven Chillrud, Darby Jack, and their colleagues from the Lamont-Doherty Earth Observatory have been using Hexoskin smart shirts and other sensors to collect data on pollution exposure in a real-world settings. This allows them to map pollution exposure around New York city. These maps can be used by cyclists and policy makers to better plan bike paths and bike lanes.
This project will have an important impact on urban design and mobility. Vice News covered their research project this week in this video:
Live Webinar - Join us on May 30, 2018 at 12PM (EST) for a Live Webinar on Respiratory Monitoring!
The Hexoskin Connected Health Platform is used by researchers in many domains all around the world. Remote & Continuous Respiratory Monitoring is a field of interest that is gaining momentum, but few non-invasive solutions exist to monitor the lung function of subjects and patients.
We invite you to our second webinar that will cover our latest results and applications in respiratory research. We will also present how Hexoskin can monitor COPD patients by using its very unique physiological data.
Webinar: Remote & Continuous Respiratory Monitoring with Hexoskin
30 May 2018, at 12:00 PM (EST) - via the Zoom Video Conferencing software
Speaker: Thu Ngan Trinh, PhD, Clinical Application Specialist at Hexoskin
Guest Speaker: Ruud van Leuteren, MSc, PhD Candidate in Neonatology at the Academic Medical Centre in Amsterdam.
If you are unable to attend, we still invite you to register and we will send you the recorded webinar by email afterward.
We look forward to your presence at this new webinar!
About Hexoskin
Founded in 2006, Hexoskin has designed a system to minimize user setup time and to maximize vital signs monitoring over long periods in a non-obstructive way with sensors embedded in a Smart Shirt. Data are synced to local and remote servers for health data management and analysis. Hexoskin offers a non-invasive solution for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress and mental illness.
Meet us at BIO in Boston on June 4-8, 2018!
Hexoskin will be attending the BIO International Convention in Boston, June 4-7, 2018 for its second year! The Smart Clothing industry's leader will present its new clinically validated collection of Smart Garments for clinical research. Hexoskin will also showcase the Hexoskin Smart, the best health monitor for continuous cardiac, respiratory, activity and sleep tracking. Hexoskin will also unveil a new solution to manage clinical trials and report real-world evidence with Machine Learning & AI. Come meet us!
View full article →Fierce Pharma: Pharma has a real-world problem, and it's the lag in its sensor adoption
Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.
"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.” That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."
Read more on Fierce Pharma.
Officers and First Responders Monitor Stress for Health Prevention
Everyday, first responders put their own lives at risk to help individuals, families, and communities. They experience frontline tragical issues, such as accidents, deaths, murders, etc. In Canada, according to the Tema Conter Memorial Trust, ‘’PTSD, Post Traumatic Stress Disorder, is a very real phenomenon facing over 20% of all First Responders’’ (CASP, 2016).
Health data are useful to get insights about the individual’s vitals. Hexoskin provides the physiological data, which gives an easy access to the vital signs information in order to determine the appropriate prevention solutions. Hexoskin can measure and report in real-time, high-level actionable data such as readiness information; remote dashboard for command center; focus and cognitive assessment; stress and fatigue monitoring; mood status monitoring; energy expenditure and metabolism monitoring.
View full article →Hexoskin's Applications & Validations in Cardiology Research
17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths (World Health Organisation). In most cases, cardiovascular diseases can be prevented.
People with cardiovascular disease with a high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidemia or already established disease) need early detection and management using counseling and medicines, as appropriate.
Hexoskin is an efficient and accurate solution to collect quantitative data about patients, every day, in real-life situations, over a long period. Researchers in many countries are performing cardiology studies with Hexoskin.
Here are a few publications about research projects that used Hexoskin to monitor cardiac and pulmonary activities from participants:
- Mouzoune, I. et al. 2nd Quebec Congress in Adaptation-Rehabilitation Research Abstract book, #128. Hexoskin Intelligent Textile Criterion Validity to Assess Cardiopulmonary Function in Healthy Population, 2017 (French).
Read the abstract here - Al Sayed, C., Vinches, L. and Halle, S. E-Health Telecommunication Systems and Networks, 6, 19-30. Validation of a Wearable Biometric System's Ability to Monitor Heart Rate in Two Different Climate Conditions under Variable Physical Activities, 2017.
Read the article here - Wilson, S.L. et al. Official Journal of American College of Sports Medicine . Vol. 8, No. 5., #1137. Heart Rate Variability in Aerobically Trained Subject vs. Untrained Subjects in Hypoxic and Normoxic Conditions, 2016.
Read the abstract here
About Hexoskin
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, write us at contact@hexoskin.com, and visit www.hexoskin.com and @Hexoskin on Twitter.
